What They Are Saying: Americans Continue to Demand Bipartisan Solutions to Hold Big Pharma Accountable, Lower Rx Prices

03-2-2020 Blog Posts

Voices from Around the Country Reiterate Need for Congress to Address Out-of-Control Prescription Drug Prices in 2020 Prescription drug prices are out-of-control and have left 58 million Americans struggling to afford their much-needed medications. Meanwhile, Big Pharma continues to evade responsibility for the crisis it created by hiking prices and gaming the system. Americans across […]

Q4 EARNINGS: BIG PHARMA PRICE HIKES KEEP THE GOOD TIMES ROLLING

02-18-2020 Blog Posts

Top Brand Name Drug Companies Bank Sky-High Profits While Evading Accountability   And that’s a wrap! Over three weeks of earnings calls have proven, yet again, that hiking prices is a profitable practice for an industry more concerned with pleasing its shareholders than helping patients. This quarter, CSRxP tracked earnings reports from 12 of the […]

BIG PHARMA EARNINGS WATCH: ASTRAZENECA

02-14-2020 Blog Posts

Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Banked Sky-High Profits After Hiking Prices Earnings reports for the fourth quarter of 2019 provide the latest evidence that Big Pharma continues to bank sky-high profits while price-gouging American patients. Today, brand name drug giant AstraZeneca announced rising profits completing a trend that holds […]

BIG PHARMA EARNINGS WATCH: ABBVIE

02-10-2020 Blog Posts

Big Pharma Giant Bests Wall Street Expectations After Hiking Prices In January   Yet another brand name drug company announced last week it had surpassed earnings expectations after hiking prices on American patients. On Friday, Big Pharma giant AbbVie reported sky-high profits after enacting a series of price hikes throughout 2019. AbbVie reported 4th quarter […]

BIG PHARMA EARNINGS WATCH: MERCK, GLAXOSMITHKLINE & BRISTOL-MYERS SQUIBB

02-7-2020 Blog Posts

Brand Name Drug Companies Keep the Good Times Rolling for Shareholders by Price-Gouging American Patients This week, three more Big Pharma giants proved yet again that hiking prices is a profitable practice for an industry more concerned with pleasing its shareholders than helping patients.  Merck, GlaxoSmithKline (GSK) and Bristol-Myers Squibb all reported sky-high profits this […]

BIG PHARMA WATCH: ANTI-COMPETITIVE CHARITY SCHEMES TAKE CENTER STAGE AT WAYS & MEANS HEARING

02-6-2020 Blog Posts

Testimony Highlights How Brand Name Drug Companies Use Nonprofits To Keep Prices High & Pad Their Bottom Line   Expert witnesses at a Wednesday hearing before the U.S. House of Representatives Committee on Ways & Means Subcommittee on Health highlighted how Big Pharma exploits nonprofit charities as a vehicle to boost their bottom line. Ge Bai, […]

DOSE OF REALITY: BIG PHARMA’S INSULIN PRICE PREDICAMENT

02-4-2020 Blog Posts

Pharmaceutical Companies to Blame for Out-of-Control Prices for Life-Saving Drug   During tonight’s State of the Union address, President Trump is expected to address the mounting crisis of affordability caused by the out-of-control price of prescription drugs. One drug in particular has been at the forefront of this crisis for millions of Americans diagnosed with […]

CSRxP LAUNCHES SEVEN-FIGURE “PROMISE” CAMPAIGN URGING CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE

02-4-2020 Press Release

Comprehensive Effort Will Target D.C., In Addition To Nine Presidential & Senate Battleground States Calling For Passage of Bipartisan Solutions to Lower Prescription Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) announced Tuesday the start of a comprehensive, seven-figure campaign targeting Washington, D.C., in addition to nine presidential and Senate battleground states, […]

BIG PHARMA WATCH: BRAND NAME DRUG COMPANIES SHAMELESSLY SKIRT STATE TRANSPARENCY LAWS

02-3-2020 Blog Posts

Congressional Action Needed to Shine a Light on Big Pharma’s Egregious Pricing Tactics & Hold the Industry Accountable In yet another example of the lengths Big Pharma will go to evade responsibility and keep prices high, a new analysis from Bloomberg Law reveals that efforts to reign in out-of-control prescription drug prices on the state-level […]

CSRxP: SOTU 2020 OFFERS PRESIDENT UNIQUE MOMENT TO LEAD ON LOWERING Rx PRICES

02-3-2020 Press Release

Trump Can Use Platform To Demand Congress Hold Big Pharma Accountable & Deliver Relief For Americans Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) said Monday that President Trump will have a unique opportunity during the 2020 State of the Union address to advance his commitment to lowering prescription drug prices – by […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.